<DOC>
	<DOCNO>NCT02564289</DOCNO>
	<brief_summary>The current study proposes investigate effect chronic snus use blood vessel . Several cardiovascular endpoint measure use various method healthy daily snus user well healthy match control .</brief_summary>
	<brief_title>Cardiovascular Effects Chronic Snus Use</brief_title>
	<detailed_description>The Swedish moist oral snuff know `` snus '' previously find primarily Scandinavia . In Sweden approximately 1 5 men habitual user snus . It estimate 3-4 % female population regular user . However , last year see shift global tobacco industry towards find novel way enter smokeless tobacco ( ST ) market . In United States Camel Marlboro brand , among others , launch array ST product similar Swedish snus . Since launch 2007 , US snus market continue grow exponential rate sell approximately 50 million can year . Smoking study extensively undoubtedly link range detrimental health effect , include cardiovascular disease . As snus recently available limited Scandinavian market , experimental epidemiological study perform . A recent meta-analysis find snus associate heart failure high risk fatal myocardial infarction stroke . Following myocardial infarction , discontinuation snus use associate 50 % decrease risk mortality . With new emerge market worldwide publicize product discrete healthier alternative cigarette , become imperative study health effect smokeless tobacco . Using well validate method investigator intend study possible effect chronic snus use vascular endothelial function , thrombosis , circulate microparticles blood arterial stiffness .</detailed_description>
	<mesh_term>Tobacco Use Disorder</mesh_term>
	<criteria>Normal clinical examination Normal ECG Normal routine blood test include serum lipid HbA1C Any form cardiovascular disease Any form systemic chronic disorder like rheumatologic metabolic disease . Active allergy within 4 week study Symptoms infection inflammation within 4 week study</criteria>
	<gender>Male</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>microvesicles , microparticles</keyword>
	<keyword>Plethysmography</keyword>
	<keyword>Snus</keyword>
	<keyword>Arterial Stiffness</keyword>
	<keyword>EPC</keyword>
</DOC>